75 related articles for article (PubMed ID: 19087546)
1. [Proteasome inhibitors sensitize ovarian cancer cells to paclitaxel induced apoptosis].
Weng DH; Li Y; Kong FF; Fan LS; Hu Y; Song XH; Xing H; Wang SX; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):770-3. PubMed ID: 19087546
[TBL] [Abstract][Full Text] [Related]
2. Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death.
Piazza F; Manni S; Tubi LQ; Montini B; Pavan L; Colpo A; Gnoato M; Cabrelle A; Adami F; Zambello R; Trentin L; Gurrieri C; Semenzato G
BMC Cancer; 2010 Oct; 10():526. PubMed ID: 20920357
[TBL] [Abstract][Full Text] [Related]
3. [Proteasome inhibitors sensitize ovarian cancer cells to cisplatin].
Li Y; Weng DH; Kong FF; Fan LS; Hu Y; Song XH; Xing H; Wang W; Ma D; Wang SX
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):445-8. PubMed ID: 21029596
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of bortezomib-induced apoptosis by TGF-beta in cultured human Tenon's fibroblasts: contribution of the PI3K/Akt signaling pathway.
Chung EJ; Moon SW; Jung SA; Cho YJ; Kim SW; Lee JH
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6232-7. PubMed ID: 20702821
[TBL] [Abstract][Full Text] [Related]
5. Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer.
Steg AD; Burke MR; Amm HM; Katre AA; Dobbin ZC; Jeong DH; Landen CN
Oncotarget; 2014 Aug; 5(16):7065-80. PubMed ID: 25216523
[TBL] [Abstract][Full Text] [Related]
6. Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.
Zhang K; Song H; Yang P; Dai X; Li Y; Wang L; Du J; Pan K; Zhang T
Cell Prolif; 2015 Apr; 48(2):249-58. PubMed ID: 25643607
[TBL] [Abstract][Full Text] [Related]
7. [Effect of extracellular signal regulated kinase signal pathway on apoptosis induced by MG262 in ovarian cancer cells].
Wang WX; Kong BH; Li P; Song K; Qu X; Cui BX; Jiang J; Zhang YZ; Yang XS
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):690-4. PubMed ID: 19087521
[TBL] [Abstract][Full Text] [Related]
8. [Effects of secoisolariciresinol diglucoside combined with bortezomib on induction of apoptosis in lung cancer cell line A549].
Li XW; Yang JR
Zhong Yao Cai; 2012 Feb; 35(2):248-53. PubMed ID: 22822672
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
[TBL] [Abstract][Full Text] [Related]
10. Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.
Saulle E; Petronelli A; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Cognetti F; Humphreys R; Peschle C; Testa U
Apoptosis; 2007 Apr; 12(4):635-55. PubMed ID: 17252198
[TBL] [Abstract][Full Text] [Related]
11. CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells.
Lin YC; Chen KC; Chen CC; Cheng AL; Chen KF
Oral Oncol; 2012 Jul; 48(7):585-93. PubMed ID: 22342571
[TBL] [Abstract][Full Text] [Related]
12. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
Kim SH; Juhnn YS; Song YS
Ann N Y Acad Sci; 2007 Jan; 1095():82-9. PubMed ID: 17404021
[TBL] [Abstract][Full Text] [Related]
13. Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β.
Gerhardt D; Bertola G; Dietrich F; Figueiró F; Zanotto-Filho A; Moreira Fonseca JC; Morrone FB; Barrios CH; Battastini AM; Salbego CG
Urol Oncol; 2014 Jan; 32(1):36.e1-9. PubMed ID: 24239461
[TBL] [Abstract][Full Text] [Related]
14. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors.
Zhu H; Zhang L; Dong F; Guo W; Wu S; Teraishi F; Davis JJ; Chiao PJ; Fang B
Oncogene; 2005 Jul; 24(31):4993-9. PubMed ID: 15824729
[TBL] [Abstract][Full Text] [Related]
15. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of lapatinib and bortezomib in human epidermal receptor 2 (HER2)-overexpressing breast cancer cells and activity of bortezomib against lapatinib-resistant breast cancer cells.
Ma C; Niu X; Luo J; Shao Z; Shen K
Cancer Sci; 2010 Oct; 101(10):2220-6. PubMed ID: 20701607
[TBL] [Abstract][Full Text] [Related]
17. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
[TBL] [Abstract][Full Text] [Related]
18. [Apoptosis in Jurkat cells induced by bortezomib combined with adriamycin].
Chen JF; Jin J
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):890-3. PubMed ID: 20193325
[TBL] [Abstract][Full Text] [Related]
19. [Effect of different concentrations of bortezomib on the expression of ERK, JNK and P38 in daunorubicin-resistant K562 cells].
Fu BB; Fan Y; Hao LC; Liao AJ; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):671-5. PubMed ID: 21729547
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production.
Gong L; Yang B; Xu M; Cheng B; Tang X; Zheng P; Jing Y; Wu GJ
Cancer Chemother Pharmacol; 2014 Jan; 73(1):69-77. PubMed ID: 24190701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]